Approximately 75-90% of patients who meet TSC standard clinical criteria harborTSC1 or TSC2 mutations (Tyburczy et al., 2015), and approximately 60-70% of TSC casesare sporadic (Sampson et al., 1989; van Slegtenhorst et al.,1997). Here, TSC2 is linked to tuberous sclerosis.